Vision restoration therapy restores sight to stroke patients

Article

Vision restoration therapy can help restore vision that has been partially lost as a result of stroke, according to a report published online, ahead of print, in Neurorehabilitation & Neural Repair.

Vision restoration therapy can help restore vision that has been partially lost as a result of stroke, according to a report published online, ahead of print, in Neurorehabilitation & Neural Repair.

Researchers at Columbia University hypothesised that restoration therapy, which involves repetitive stimulation of the zones adjacent to the blind area, can modestly enlarge the field of vision in patients who lost the ability to see in one eye. According to the researchers, this home-based therapy induces specific changes in the brain?s response to stimuli in the trained border-zone location.

Based on the results of their research so far, the authors suggest that visual restoration therapy appears to alter brain activity. They went on to conclude that demonstrating a visual field's specific training effect on brain activity may provide an important starting point for understanding the potential for visual therapy in partially blind stroke patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.